Monday, February 5, 2018

Two new secondary metabolites from a fungus of the genus Robillarda - Journal of Antibiotics

Two new secondary metabolites from a fungus of the genus Robillarda

Two new secondary metabolites from a fungus of the genus <i>Robillarda</i>, Published online: 05 February 2018; doi:10.1038/s41429-017-0015-x

Two new secondary metabolites from a fungus of the genus Robillarda

from The Journal of Antibiotics - Issue - nature.com science feeds http://ift.tt/2EgpQvT
via IFTTT

Friday, February 2, 2018

Statement from Jeffrey Shuren, M.D., J.D., director of the FDA’s Center for Devices and Radiological Health on the recent National Toxicology Program draft report on radiofrequency energy exposure - FDA Press Releases

One part of the Food and Drug Administration’s mission is to ensure the safety of electronic products that emit radiation, like televisions and cell phones. These types of products are part of Americans’ daily life and we take our duty to protect consumers with the utmost gravity. With cell phones, we have relied extensively on a myriad scientific evidence developed over many years to help inform our regulatory thinking. Although the Federal Communications Commission (FCC) sets the standard for radiofrequency energy exposure limits from cell phones, the FCC relies on the FDA and other health agencies for scientific expertise and input regarding those standards.

from Food and Drug Administration--Press Releases http://ift.tt/2GGi9gQ
via IFTTT

JFC International Inc. Issues Allergy Alert on Undeclared Crustacean Shellfish (Shrimp, Crab) in Daisho Kimchi Hot Pot Soup Base - FDA Safety Alerts & Drug Recalls

JFC International Inc. of Los Angeles, CA is voluntarily recalling a Kimchi Hot Pot Soup Base because it was found to contain undeclared Crustacean Shellfish (Shrimp, Crab). Individuals who have allergies to crustacean shellfish (shrimp, crab) runs the risk of a serious life-threatening allergic reaction if they consume the product. One incident has been reported to date in connection with this issue.

from Food and Drug Administration--Recalls/Safety Alerts http://ift.tt/2GEZS3z
via IFTTT

Thursday, February 1, 2018

Kareway Products, Inc Issues Voluntary Nationwide Recall of Gericare Eye Wash due to Complaints Received on Potential Product Contamination which Compromises Sterility - FDA Safety Alerts & Drug Recalls

Compton, California, Kareway Products, Inc is voluntarily recalling 60,000 lots of Gericare Eye Wash, Sterile Eye Irrigation Solution, 4 fluid ounces to the hospital, retail or consumer level. The product has been found to have potential microbial contamination which compromises sterility.

from Food and Drug Administration--Recalls/Safety Alerts http://ift.tt/2DTvJjg
via IFTTT

Statement from FDA Commissioner Scott Gottlieb, M.D., on ongoing efforts to mitigate impact of saline shortages during this flu season - FDA Press Releases

FDA provides update on ongoing efforts to mitigate impact of saline shortages and monitor other critical products during flu season

from Food and Drug Administration--Press Releases http://ift.tt/2rZoEIr
via IFTTT

Bafilomycin C1 exert antifungal effect through disturbing sterol biosynthesis in Candida albicans - Journal of Antibiotics

Bafilomycin C1 exert antifungal effect through disturbing sterol biosynthesis in Candida albicans

Bafilomycin C1 exert antifungal effect through disturbing sterol biosynthesis in <i>Candida albicans</i>, Published online: 01 February 2018; doi:10.1038/s41429-017-0009-8

Bafilomycin C1 exert antifungal effect through disturbing sterol biosynthesis in Candida albicans

from The Journal of Antibiotics - Issue - nature.com science feeds http://ift.tt/2DTfUFj
via IFTTT

Consequences of Long-Term Oral Bisphosphonate Treatment - American Geriatric Society



from Journal of the American Geriatrics Society http://ift.tt/2E1XRA3
via IFTTT